Drug Shortage Report for HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ
| Report ID | 102491 |
| Drug Identification Number | 02209721 |
| Brand name | HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ |
| Common or Proper name | Hepain Sodium |
| Company Name | B. BRAUN MEDICAL INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE HEPARIN SODIUM |
| Strength(s) | 5G 10000UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 250mL |
| ATC code | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2019-12-05 |
| Estimated end date | 2020-11-02 |
| Actual end date | 2020-11-13 |
| Shortage status | Resolved |
| Updated date | 2020-11-18 |
| Company comments | Product now available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 824 TWELFTH AVENUE BETHLEHEM, PENNSYLVANIA UNITED STATES 18018 |
| Company contact information | Cindy Katsempris; [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2020-01-07 | French | Compare |
| v1 | 2020-01-07 | English | Compare |